API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
0
EU WC
Listed Suppliers
0
0
USA (Orange Book)
Europe
Canada
0
Australia
0
South Africa
Uploaded Dossiers
U.S. Medicaid
0
Annual Reports
0
0
38
PharmaCompass offers a list of Amifostine API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Amifostine manufacturer or Amifostine supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Amifostine manufacturer or Amifostine supplier.
PharmaCompass also assists you with knowing the Amifostine API Price utilized in the formulation of products. Amifostine API Price is not always fixed or binding as the Amifostine Price is obtained through a variety of data sources. The Amifostine Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Amifostine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Amifostine, including repackagers and relabelers. The FDA regulates Amifostine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Amifostine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Amifostine manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Amifostine supplier is an individual or a company that provides Amifostine active pharmaceutical ingredient (API) or Amifostine finished formulations upon request. The Amifostine suppliers may include Amifostine API manufacturers, exporters, distributors and traders.
click here to find a list of Amifostine suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Amifostine DMF (Drug Master File) is a document detailing the whole manufacturing process of Amifostine active pharmaceutical ingredient (API) in detail. Different forms of Amifostine DMFs exist exist since differing nations have different regulations, such as Amifostine USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Amifostine DMF submitted to regulatory agencies in the US is known as a USDMF. Amifostine USDMF includes data on Amifostine's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Amifostine USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Amifostine suppliers with USDMF on PharmaCompass.
A Amifostine written confirmation (Amifostine WC) is an official document issued by a regulatory agency to a Amifostine manufacturer, verifying that the manufacturing facility of a Amifostine active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Amifostine APIs or Amifostine finished pharmaceutical products to another nation, regulatory agencies frequently require a Amifostine WC (written confirmation) as part of the regulatory process.
click here to find a list of Amifostine suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Amifostine as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Amifostine API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Amifostine as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Amifostine and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Amifostine NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Amifostine suppliers with NDC on PharmaCompass.
Amifostine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Amifostine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Amifostine GMP manufacturer or Amifostine GMP API supplier for your needs.
A Amifostine CoA (Certificate of Analysis) is a formal document that attests to Amifostine's compliance with Amifostine specifications and serves as a tool for batch-level quality control.
Amifostine CoA mostly includes findings from lab analyses of a specific batch. For each Amifostine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Amifostine may be tested according to a variety of international standards, such as European Pharmacopoeia (Amifostine EP), Amifostine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Amifostine USP).